138 related articles for article (PubMed ID: 11300293)
1. Histopathological characterization of melorheostosis.
Hoshi K; Amizuka N; Kurokawa T; Nakamura K; Shiro R; Ozawa H
Orthopedics; 2001 Mar; 24(3):273-7. PubMed ID: 11300293
[TBL] [Abstract][Full Text] [Related]
2. Somatic activating mutations in MAP2K1 cause melorheostosis.
Kang H; Jha S; Deng Z; Fratzl-Zelman N; Cabral WA; Ivovic A; Meylan F; Hanson EP; Lange E; Katz J; Roschger P; Klaushofer K; Cowen EW; Siegel RM; Marini JC; Bhattacharyya T
Nat Commun; 2018 Apr; 9(1):1390. PubMed ID: 29643386
[TBL] [Abstract][Full Text] [Related]
3. Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.
Jha S; Fratzl-Zelman N; Roschger P; Papadakis GZ; Cowen EW; Kang H; Lehky TJ; Alter K; Deng Z; Ivovic A; Flynn L; Reynolds JC; Dasgupta A; Miettinen M; Lange E; Katz J; Klaushofer K; Marini JC; Siegel RM; Bhattacharyya T
J Bone Miner Res; 2019 Jan; 34(1):145-156. PubMed ID: 30138550
[TBL] [Abstract][Full Text] [Related]
4. Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.
Fratzl-Zelman N; Roschger P; Kang H; Jha S; Roschger A; Blouin S; Deng Z; Cabral WA; Ivovic A; Katz J; Siegel RM; Klaushofer K; Fratzl P; Bhattacharyya T; Marini JC
J Bone Miner Res; 2019 May; 34(5):883-895. PubMed ID: 30667555
[TBL] [Abstract][Full Text] [Related]
5. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
[TBL] [Abstract][Full Text] [Related]
6. Bone Features of Unaffected Skeletal Sites in Melorheostosis: A Case Report.
Indirli R; Messina C; Longhi M; Guabello G; Corbetta S
J Clin Densitom; 2020; 23(4):690-694. PubMed ID: 32057643
[TBL] [Abstract][Full Text] [Related]
7. Melorheostosis.
Rozencwaig R; Wilson MR; McFarland GB
Am J Orthop (Belle Mead NJ); 1997 Feb; 26(2):83-9. PubMed ID: 9040882
[TBL] [Abstract][Full Text] [Related]
8. VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis.
Allbritton-King JD; Maity J; Patel A; Colbert RA; Navid F; Bhattacharyya T
J Bone Miner Res; 2023 Dec; 38(12):1834-1845. PubMed ID: 37737377
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of melorheostosis by bone scan.
Eugenidis N; Locher J
Eur J Nucl Med; 1979 Feb; 4(1):75-6. PubMed ID: 499231
[No Abstract] [Full Text] [Related]
10. Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.
Han X; Xu Y; Wei Z; Wang C; Yue H; Zhang Z
Mol Genet Genomic Med; 2022 Oct; 10(10):e2043. PubMed ID: 36004822
[TBL] [Abstract][Full Text] [Related]
11. Melorheostosis--a very rare entity in neurosurgery.
Lang G; Schroeder H; Warzok RW
Neurosurg Rev; 1993; 16(3):229-32. PubMed ID: 8272212
[TBL] [Abstract][Full Text] [Related]
12. CT analysis of anatomical distribution of melorheostosis challenges the sclerotome hypothesis.
Jha S; Laucis N; Kim L; Malayeri A; Dasgupta A; Papadakis GZ; Karantanas A; Torres M; Bhattacharyya T
Bone; 2018 Dec; 117():31-36. PubMed ID: 30218789
[TBL] [Abstract][Full Text] [Related]
13. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis.
Kim JE; Kim EH; Han EH; Park RW; Park IH; Jun SH; Kim JC; Young MF; Kim IS
J Cell Biochem; 2000 Mar; 77(2):169-78. PubMed ID: 10723084
[TBL] [Abstract][Full Text] [Related]
14. Distribution and Functional Consequences of Somatic MAP2K1 Variants in Affected Skin Associated with Bone Lesions in Melorheostosis.
Jha S; Ivovic A; Kang H; Meylan F; Hanson EP; Rimland C; Lange E; Katz J; McBride A; Warner AC; Edmondson EF; Cowen EW; Marini JC; Siegel RM; Bhattacharyya T
J Invest Dermatol; 2021 Mar; 141(3):688-692.e11. PubMed ID: 32791068
[No Abstract] [Full Text] [Related]
15. Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.
Fowlkes JL; Bunn RC; Ray PD; Kalaitzoglou E; Uppuganti S; Unal M; Nyman JS; Thrailkill KM
Bone; 2020 Jan; 130():115106. PubMed ID: 31689526
[TBL] [Abstract][Full Text] [Related]
16. [Melorheostosis of the foot: a case report of a rare entity].
Craiovan B; Zeiler G; Delling G; Schuh A
Zentralbl Chir; 2006 Dec; 131(6):517-20. PubMed ID: 17206574
[TBL] [Abstract][Full Text] [Related]
17. Melorheostosis with an associated para-articular enhancing soft tissue mass.
Manning P; Nguyen TB; Smitaman E
Clin Imaging; 2019; 56():9-12. PubMed ID: 30825667
[TBL] [Abstract][Full Text] [Related]
18. Arthroscopic findings in melorheostosis.
Minarro JC; Perez AJ; Benítez PC; Jordán AL; Martinez AD
J Clin Rheumatol; 2015 Apr; 21(3):160-3. PubMed ID: 25807097
[TBL] [Abstract][Full Text] [Related]
19. Melorheostosis: a Rare Sclerosing Bone Dysplasia.
Kotwal A; Clarke BL
Curr Osteoporos Rep; 2017 Aug; 15(4):335-342. PubMed ID: 28676968
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection of melorheostosis in the ribs.
Chanda B; Millner RW
Ann Thorac Surg; 2007 Apr; 83(4):1518-9. PubMed ID: 17383370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]